Up-regulation of metallothionein gene expression in Parkinsonian astrocytes

Neurogenetics

Volumn 12, Issue 4, 2011, Pages 295-305

  Michael, Gregory J ^a   Esmailzadeh, Sharmin ^b   Moran, Linda B ^b   Christian, Lynne ^b   Pearce, Ronald K B ^b   Graeber, Manuel B ^b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cell death; Glial degeneration; Megalin; Neuroprotection; Reactive astrocytes

Indexed keywords

MEGALIN; METALLOTHIONEIN;

ADULT; AGED; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; UPREGULATION;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ASTROCYTES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; HUMANS; MALE; METALLOTHIONEIN; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT; UP-REGULATION;

PARKINSONIA;

EID: 84855289046     PISSN: 13646745     EISSN: 13646753     Source Type: Journal    
DOI: 10.1007/s10048-011-0294-5     Document Type: Article

References (68)

1. Mirza B, Hadberg H, Thomsen P, Moos T (2000) The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95:425-432
2. Durrenberger PF, Filiou MD, Moran LB, Michael GJ, Novoselov S, Cheetham ME, Clark P, Pearce RK, Graeber MB (2009) DnaJB6 is present in the core of Lewy bodies and is highly upregulated in parkinsonian astrocytes. J Neurosci Res 87:238-245
3. Stankovic RK, Chung RS, Penkowa M (2007) Metallothioneins I and II: neuroprotective significance during CNS pathology. Int J Biochem Cell Biol 39:484-489 (Pubitemid 46096789)
4. Cozzi B, Giacomello M, Zambenedetti P, Bolognin S, Rossipal E, Peruffo A, Zatta P (2010) Ontogenesis and migration of metallothionein I/II-containing glial cells in the human telencephalon during the second trimester. Brain Res 1327:16-23
5. Capdevila M, Atrian S (2011) Metallothionein protein evolution: a miniassay. J Biol Inorg Chem. doi:10.1007/s00775-011-0798-3
6. Hozumi I, Yamada M, Uchida Y, Ozawa K, Takahashi H, Inuzuka T (2008) The expression of metallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph Lateral Scler 9:294-298
7. Chung RS, Vickers JC, Chuah MI, West AK (2003) Metallothionein-IIA promotes initial neurite elongation and post-injury reactive neurite growth and facilitates healing after focal cortical brain injury. J Neurosci 23:3336-3342 (Pubitemid 36531975)
8. Miyazaki I, Asanuma M, Hozumi H, Miyoshi S (2007) Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. FEBS Lett 581:5003-5008 (Pubitemid 47531776)
9. Yamashita S, Okauchi M, Hua Y, Liu W, Keep R, Xi G (2008) Metallothionein and brain injury after intracerebral hemorrhage. Acta Neurochir Suppl 105:37-40
10. Leung Y, Pankhurst M, Dunlop S, Ray S, Dittmann J, Eaton E, Palumaa P, Sillard R, Chuah M, West A, Chung R (2010) Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways. Exp Neurol 221:98-106
11. Penkowa M, Cáceres M, Borup R, Nielsen FC, Poulsen CB, Quintana A, Molinero A, Carrasco J, Florit S, Giralt M, Hidalgo J (2006) Novel roles for metallothionein-I+II (MT-I+II) in defenseresponses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I+II knockout mice. J Neurosci Res 84:1452-1474 (Pubitemid 44683139)
12. Mikol J, Vital C, Wassef M, Chappuis P, Poupon J, Lecharpentier M, Woimant F (2005) Extensive cortico-subcortical lesions in Wilson's disease: clinico-pathological study of two cases. Acta Neuropathol 110:451-458 (Pubitemid 41672338)
13. Wunderlich K, Leveillard T, Penkowa M, Zrenner E, Perez M (2010) Altered expression of metallothionein-I and -II and their receptor megalin in inherited photoreceptor degeneration. Investig Ophthalmol Vis Sci 51:4809-4820
14. Vašák M, Meloni G (2011) Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem. doi:10.1007/s00775-011-0799-2
15. Pedersen MØ, Jensen R, Pedersen DS, Skjolding AD, Hempel C, Maretty L, Penkowa M (2009) Metallothionein-I+II in neuroprotection. BioFactors (Oxford, England) 35:315-325
16. Hozumi I, Suzuki J, Kanazawa H, Hara A, Saio M, Inuzuka T, Miyairi S, Naganuma A, Tohyama C (2008) Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci Lett 438:54-58
17. Lee S, Park M, Kim H, Koh J (2010) Metallothionein-3 regulates lysosomal function in cultured astrocytes under both normal and oxidative conditions. Glia 58:1186-1196
18. Lee S, Koh J (2010) Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 3:30
19. Kim D, Kim EH, Kim C, Sun W, Kim HJ, Uhm CS, Park SH, Kim H (2003) Differential regulation of metallothionein-I, II, and III mRNA expression in the rat brain following kainic acid treatment. Neuroreport 14:679-682 (Pubitemid 36570921)
20. Young JK, Garvey JS, Huang PC (1991) Glial immunoreactivity for metallothionein in the rat brain. Glia 4:602-610
21. Chung RS, Adlard PA, Dittmann J, Vickers JC, Chuah MI, West AK (2004) Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J Neurochem 88:454-461 (Pubitemid 38084561)
22. Wakida SM, Hozumi I, Satoh NH, Inuzuka T, Hara H (2007) Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience 148:105-114 (Pubitemid 47211609)
23. Beltramini M, Di Pisa C, Zambenedetti P, Wittkowski W, Mocchegiani E, Musicco M, Zatta P (2004) Zn and Cu alteration in connection with astrocyte metallothionein I/II overexpression in the mouse brain upon physical stress. Glia 47:30-34 (Pubitemid 38879703)
24. Zambenedetti P, Giordano R, Zatta P (1998) Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease. J Chem Neuroanat 15:21-26 (Pubitemid 28377051)
25. Buniatian GH, Hartmann HJ, Traub P, Wiesinger H, Albinus M, Nagel W, Shoeman R, Mecke D, Weser U (2002) Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes. Anat Rec 267:296-306 (Pubitemid 34827617)
26. Adachi T, Satoh M, Pramanik R, Kuroda S, Ishido M, Kunimoto M (2006) Region-dependent differences and alterations of protective thiol compound levels in cultured astrocytes and brain tissues. Biol Pharm Bull 29:1466-1469
27. Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand W, Hidalgo J (2006) Metallothionein-I and -III expression in animal models of Alzheimer disease. Neuroscience 143:911-922 (Pubitemid 44834444)
28. Hanlon J, Monks E, Hughes C, Weavers E, Rogers M (2002) Metallothionein in bovine spongiform encephalopathy. J Comp Pathol 127:280-289 (Pubitemid 35373411)
29. Vorbrodt AW, Dobrogowska DH, Meeker HC, Carp RI (2006) Quantitative immunogold study of increased expression of metallothionein-I/II in the brain perivascular areas of diabetic scrapie-infected mice. J Mol Histol 37:143-151 (Pubitemid 44532064)
30. Zatta P, Raso M, Zambenedetti P, Wittkowski W, Messori L, Piccioli F, Mauri PL, Beltramini M (2005) Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment. Cell Mol Life Sci 62:1502-1513 (Pubitemid 40922952)
31. Zatta P, Zambenedetti P, Musicco M, Adorni F (2005) Metallothionein-I-II and GFAP positivity in the brains from frontotemporal dementia patients. J Alzheimers Dis 8:109-115
32. Zambenedetti P, Schmitt HP, Zatta P (2002) Metallothionein I-II immunocytochemical reactivity in Binswanger's encephalopathy. J Alzheimers Dis 4:459-466 (Pubitemid 36142835)
33. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 7:1-11 (Pubitemid 43327678)
34. Zhang Y, James M, Middleton FA, Davis RL (2005) Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137:5-16 (Pubitemid 41076605)
35. Moran LB, Graeber MB (2008) Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation. Neurogenetics 9:1-13
36. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, Grünblatt E, Moran LB, Mandel SA, Riederer P, Miller RM, Federoff HJ, Wüllner U, Papapetropoulos S, Youdim MB, Cantuti-Castelvetri I, Young AB, Vance JM, Davis RL, Hedreen JC, Adler CH, Beach TG, Graeber MB, Middleton FA, Rochet JC, Scherzer CR, Global PD Gene Expression (GPEX) Consortium (2010) PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2:52ra73
37. Peirson SN, Butler JN, Foster RG (2003) Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res 31:e73
38. Aschner M (1997) Astrocyte metallothioneins (MTs) and their neuroprotective role. Ann N Y Acad Sci 825:334-347
39. Fitzgerald M, Nairn P, Bartlett CA, Chung RS, West AK, Beazley LD (2007) Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp Brain Res 183:171-180 (Pubitemid 47497715)
40. Reinecke F, Levanets O, Olivier Y, Louw R, Semete B, Grobler A, Hidalgo J, Smeitink J, Olckers A, Van der Westhuizen FH (2006) Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells. Biochem J 395:405-415
41. Futakawa N, Kondoh M, Ueda S, Higashimoto M, Takiguchi M, Suzuki S, Sato M (2006) Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors. Biol Pharm Bull 29:2016-2020 (Pubitemid 44510801)
42. Dhanasekaran M, Albano CB, Pellet L, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Brown-Borg H, Ebadi M (2008) Role of lipoamide dehydrogenase and metallothionein on 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Neurochem Res 33:980-984
43. Tanji K, Irie Y, Uchida Y, Mori F, Satoh K, Mizushima Y, Wakabayashi K (2003) Expression of metallothionein-III induced by hypoxia attenuates hypoxia-induced cell death in vitro. Brain Res 976:125-129 (Pubitemid 36588544)
44. Hidalgo J, Penkowa M, Espejo C, Martínez-Cáceres EM, Carrasco J, Quintana A, Molinero A, Florit S, Giralt M, Ortega-Aznar A (2006) Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med (Maywood, NJ) 231:1450-1458 (Pubitemid 44547836)
45. Giralt M, Carrasco J, Penkowa M, Morcillo MA, Santamaria J, Campbell IL, Hidalgo J (2001) Astrocyte-targeted expression ofinterleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain. Exp Neurol 168:334-346 (Pubitemid 32289769)
46. Molinero A, Penkowa M, Hernández J, Camats J, Giralt M, Lago N, Carrasco J, Campbell IL, Hidalgo J (2003) Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6. J Neuropathol Exp Neurol 62:315-328 (Pubitemid 36330682)
47. Penkowa M, Camats J, Giralt M, Molinero A, Hernández J, Carrasco J, Campbell IL, Hidalgo J (2003) Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 42:287-306 (Pubitemid 36538341)
48. Penkowa M, Poulsen C, Carrasco J, Hidalgo J (2002) M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6- aminonicotinamide treatment. Exp Neurol 176:308-321 (Pubitemid 35193347)
49. Wiese L, Kurtzhals JA, Penkowa M (2006) Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol 200:216-226 (Pubitemid 44097022)
50. Cai L, Iskander S, Cherian MG, Hammond RR (2004) Zinc- or cadmium-pre-induced metallothionein protects human central nervous system cells and astrocytes from radiation-induced apoptosis. Toxicol Lett 146:217-226 (Pubitemid 37542397)
51. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J (2002) Metallothionein-1+2 protect the CNS after a focal brain injury. Exp Neurol 173:114-128 (Pubitemid 34081731)
52. Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J (2005) Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79:522-534 (Pubitemid 40283352)
53. Ebadi M, Sharma SK, Ghafourifar P, Brown-Borg H, El Refaey H (2005) Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins. Meth Enzymol 396:276-298
54. Ebadi M, Sharma S (2006) Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Exp Biol Med (Maywood, NJ) 231:1576-1583 (Pubitemid 44547853)
55. Acarin L, Peluffo H, Barbeito L, Castellano B, González B (2005) Astroglial nitration after postnatal excitotoxic damage: correlation with nitric oxide sources, cytoskeletal, apoptotic and antioxidant proteins. J Neurotrauma 22:189-200
56. Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M (2006) Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 28:125-141
57. Sharma SK, El Refaey H, Ebadi M (2006) Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10. Brain Res Bull 70:22-32
58. Ransom BR, Kunis DM, Irwin I, Langston JW (1987) Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci Lett 75:323-328 (Pubitemid 17042867)
59. Ishida Y, Nagai A, Kobayashi S, Kim SU (2006) Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J Neuropathol Exp Neurol 65:66-77
60. Solano RM, Casarejos MJ, Menéndez-Cuervo J, Rodriguez-Navarro JA, García de Yébenes J, Mena MA (2008) Glial dysfunction in parkin null mice: effects of aging. J Neurosci 28:598-611 (Pubitemid 351159033)
61. Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol 114:231-241 (Pubitemid 47226149)
62. McGeer PL, McGeer EG (2008) Glial reactions in Parkinson's disease. Mov Disord 23:474-483
63. Duke DC, Moran LB, Kalaitzakis ME, Deprez M, Dexter DT, Pearce RK, Graeber MB (2006) Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease. Neurogenetics 7:139-148 (Pubitemid 44078291)
64. Chung RS, Penkowa M, Dittmann J, King CE, Bartlett C, Asmussen JW, Hidalgo J, Carrasco J, Leung YK, Walker AK, Fung SJ, Dunlop SA, Fitzgerald M, Beazley LD, Chuah MI, Vickers JC, West AK (2008) Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 283:15349-15358
65. Potter E, Cheng Y, Knight J, Gordish-Dressman H, Natale J (2007) Metallothionein I and II attenuate the thalamic microglial response following traumatic axotomy in the immature brain. J Neurotrauma 24:28-42 (Pubitemid 46214410)
66. Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S (2007) Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 8:26
67. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA, Mirnics K (2011) Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16(7):751-762
68. Hahn Y, Lee B (2006) Human-specific nonsensemutations identified by genome sequence comparisons. Hum Genet 119(1-2):169-178